Other
Anterior Chamber (AC) Tap
Anterior Chamber (AC) Tap is an intervention with 3 clinical trials. Historical success rate of 33.3%.
Total Trials
3
Max Phase
—
Type
OTHER
Molecule
—
Success Metrics
Clinical Success Rate
33.3%
Based on 1 completed trials
Completion Rate
33%(1/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
2(67%)
Phase Distribution
No phase data available
Trial Status & Enrollment
Completion Rate
33.3%
1 of 3 finished
Non-Completion Rate
66.7%
2 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(1)
Terminated(2)
Detailed Status
Terminated2
Completed1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
33.3%
Trials by Status
terminated267%
completed133%
Recent Activity
0 active trials
Showing 3 of 3
Clinical Trials (3)
Showing 3 of 3 trials
NCT02875704
Oxidative Stress In Stargardt Disease, Age Related Macular Degeneration and Diabetic Retinopathy
NCT02688309
Pro-permeability and Pro-fibrosis Factors in the Aqueous of Patients With Retinal Diseases
NCT01949623
Biomarkers In Retinitis Pigmentosa (BIRP)
All 3 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 3